data13F

PCVX – Vaxcyte Inc

Held by 1 of 30 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares40,377
Combined reported value$2.3M

PCVX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Ray Dalio narrow view 0.01 Reduced 19.6%40,377$2.3MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view Reduced 19.6%40,3770.00
Q2 2026Seth Klarman Closed00.91
Q2 2026Ray Dalio narrow view Added 289.2%50,2170.01
Q1 2026Seth Klarman New800,0000.91
Q1 2026Ray Dalio narrow view New12,9030.00
Q4 2025Ray Dalio narrow view Closed00.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Ray Dalio narrow view Added 289.2%50,2170.01
Q1 2026Seth Klarman New800,0000.91
Q1 2026Ray Dalio narrow view New12,9030.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Ray Dalio narrow view Reduced 19.6%40,3770.00
Q2 2026Seth Klarman Closed00.91
Q4 2025Ray Dalio narrow view Closed00.00

History

2 peakQ3 2026: 1 tracked investors
Q3 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ3 2025: 1 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20242026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ray Dalio40.4K50.2K12.9K–11.9K–––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).